How Lumenci charted a semiconductor portfolio from public documents alone, and helped close the sale

Sometimes, and it depends on the claim. Where the claim reads on architecture, interfaces, or behaviour that datasheets, standards documents, and technical literature describe, the public record can carry it. Where it reads on internal circuit structure, it usually cannot, and that gap is worth knowing before a buyer finds it.

Because a buyer cannot assess semiconductor claims from the patent text alone. The technology is dense, the claims are abstract, and without a chart showing what the patent reads on in a real product, most buyers will not spend the time to work it out themselves.

Whether the claims read on products that are shipping, how defensible that read is, and whether the assets are still relevant to where the industry is going. A chart answers the first two. Market analysis answers the third.

When the claims read on structures inside the die that no public document describes. For a sale, that is a different and more expensive exercise, so it is usually reserved for assets going to enforcement. Lumenci provides semiconductor reverse engineering where a matter requires it.

Yes. Claim charting is often the first engagement, for a sale, a licensing approach, or a pre-filing assessment. For a sale it is usually paired with market analysis.

Yes. Charting establishes what the patents read on, and valuation turns that into a number a buyer or seller can work with. Lumenci provides patent valuation as a standalone engagement.